Back

Safety and efficacy of neladenoson bialanate in patients with chronic heart failure and reduced ejection fraction.

27 August 2018 (17:09 - 17:17)
Organised by:
Congress Presentation Part of: Late Breaking Science in Heart Failure Chronic Heart Failure, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Adriaan Voors

University Medical Centre Groningen, Groningen (Netherlands (The))

10 More presentations in this session

Presentation thumbnail
Panel discussants.
Video
Presentation thumbnail
REDUCE LAP-HF I - Transcatheter InterAtrial Shunt Device for Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I): 1-year Results from the Phase 2
Doctor T. Feldman (Evanston, US)
Slides Video
Presentation thumbnail
Panel discussion.
Video
Presentation thumbnail
PROMIS-HFpEF - Microvascular dysfunction in heart failure with preserved ejection fraction (HFpEF): Evidence from the prospective multicenter PRevalence Of Microvascular dySfunction in HFpEF
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Panel discussion.
Video

Access the full session

Session thumbnail
Late Breaking Science in Heart Failure

The Event

Event poster

ESC Congress 2018

27 August 2018 17:09 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources